XML 34 R24.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stockholders' Equity (Tables)
9 Months Ended
Apr. 01, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Compensation Expense for Share-based Compensation Awards
Total compensation expense for share-based awards included in our condensed consolidated statements of operations for the third quarter and first three quarters of fiscal 2016 and 2015 was as follows:
 
Quarter Ended
 
Three Quarters Ended
(In millions)
April 1,
2016
 
April 3,
2015
 
April 1,
2016
 
April 3,
2015
By Expense Category:
 
 
 
 
 
 
 
Cost of revenues
$
0.1

 
$
0.1

 
$
0.1

 
$
0.1

Research and development

 

 
0.1

 
0.1

Selling and administrative
0.4

 
0.6

 
1.2

 
1.5

Total share-based compensation expense
$
0.5

 
$
0.7

 
$
1.4

 
$
1.7

By Types of Award:
 
 
 
 
 
 
 
Options
$
0.2

 
$
0.4

 
$
0.7

 
$
1.2

Restricted and performance stock awards and units
0.3

 
0.3

 
0.7

 
0.5

Total share-based compensation expense
$
0.5

 
$
0.7

 
$
1.4

 
$
1.7

Schedule of Stock Options Valuation Assumptions
A summary of the significant weighted average assumptions we used in the Black-Scholes valuation model is as follows:
 
Quarter Ended
 
Three Quarters Ended
 
April 1,
2016
 
April 3,
2015
 
April 1,
2016
 
April 3,
2015
Expected dividends
N/A
 
%
 
N/A
 
%
Expected volatility
N/A
 
54.0
%
 
N/A
 
53.9
%
Risk-free interest rate
N/A
 
1.09
%
 
N/A
 
1.13
%
Expected term (years)
N/A
 
4.33

 
N/A
 
4.25

Weighted average grant date fair value per share granted
N/A
 
$0.56
 
N/A
 
$0.55
Schedule of Market Condition Awards Valuation Assumptions
A summary of the significant weighted average assumptions we used in the Monte Carlo simulation model is as follows:
 
Quarter Ended
 
Three Quarters Ended
 
April 1,
2016
 
April 3,
2015
 
April 1,
2016
 
April 3,
2015
Expected dividends
N/A
 
N/A
 
%
 
N/A
Expected volatility
N/A
 
N/A
 
52.43
%
 
N/A
Risk-free interest rate
N/A
 
N/A
 
1.21
%
 
N/A
Weighted average grant date fair value per share granted
N/A
 
N/A
 
0.21

 
N/A